Apparatus and methods for ultrasonically enhanced intraluminal therapy

• US 5,725,494 A
• Filed: 11/30/1995
• Issued: 03/10/1998
• Est. Priority Date: 11/30/1995
• Status: Expired due to Fees

• Current Assignee: PharmaSonics, Inc.
• Original Assignee: PharmaSonics, Inc.
• Inventors: Brisken, Axel F.
• Primary Examiner(s): Bockelman, Mark
• Application Number:
  US08/565,575
• Time in Patent Office: 831 Days
• Field of Search: 606/169, 607/97, 604/22, 601/2, 310/26
• US Class Current: 604/22
• CPC Class Codes: A61B 17/2202 the ultrasound transducer being inside patient's body at the distal end of the catheter
• CPC Class Codes: A61B 2017/22021 electric leads passing through the catheter
• CPC Class Codes: A61B 2017/22038 with a guide wire
• CPC Class Codes: A61B 2017/22084 stone- or thrombus-dissolving

Abstract

An ultrasonic catheter comprises a catheter body having a resonantly vibrating assembly at its distal end. The resonantly vibrating assembly comprises a tail mass, an interface member, and a spring element which connects the tail mass to the interface member. An interface surface is formed on the interface member and is forwardly disposed at the distal end of the catheter. A longitudinally oscillating driver is disposed between the tail mass and the interface member, and the catheter can be connected to a suitable power supply to induce oscillations in the driver. The driver is typically a piezoelectric device, such as a tubular piezoelectric transducer or a piezoelectric stack. The characteristics of the interface member, spring element, and longitudinally oscillating driver are selected so that the interface member may be resonantly vibrated at an ultrasonic frequency. The catheter is useful for treating luminal conditions, such as vascular clot and plaque. Optionally, a therapeutic agent may be delivered through the catheter simultaneously with the application of ultrasonic energy.

Claims

1. A catheter comprising:

a catheter body having a proximal end and a distal end;

a tail mass attached to the catheter body;

a longitudinally oscillating driver engaging and extending distally from the tail mass;

an interface member engaging a distally forward surface of the oscillating driver, wherein the mass of the interface member is much less than that of the tail mass; and

a spring element connecting the tail mass to the interface member, wherein the spring element has a spring force which is selected to permit resonant driving by the longitudinally oscillating driver.

2. A catheter as in claim 1, wherein the longitudinally oscillating driver comprises a longitudinally oscillating member selected from the group consisting of piezoelectric elements and magnetostrictive elements.

3. A catheter as in claim 2, wherein the longitudinally oscillating member comprises a hollow piezoelectric cylinder having an inner cylindrical electrode and an outer cylindrical electrode.

4. A catheter as in claim 3, wherein piezoelectric cylinder has dimensions and is composed of a material which provide oscillation at a frequency in the range from 10 kHz to 300 kHz.

5. A catheter as in claim 4, wherein the piezoelectric cylinder is composed of a lead zirconate titinate, has a length in the range from 2 mm to 2 cm, an outer diameter in the range from 1 mm to 4 mm, and a wall thickness in the range from 0.1 mm to 0.5 mm.

6. A catheter as in claim 2, wherein the longitudinally oscillating member comprises a plurality of ceramic disks having electrodes therebetween.

7. A catheter as in claim 1, wherein the tail mass has a mass which is at least four times the mass of the interface member.

8. A catheter as in claim 7, wherein the tail mass has a mass in the range from 0.1 gm to 10 gm and the interface member has a mass in the range from 0.01 gm to 1 gm.

9. A catheter as in claim 1, wherein the spring element comprises at least one rod secured at a proximal end to the tail mass and at a distal end to the interface member.

10. A catheter as in claim 9, wherein the spring element consists of a single rod disposed coaxially within the catheter.

11. A catheter as in claim 9, wherein the spring element comprises at least two parallel rod members disposed symmetrically about the axis of the catheter body.

12. A catheter as in claim 1, wherein the interface member includes a distally disposed interface surface which forwardly transmits longitudinal oscillations into the environment surrounding the distal end of the catheter.

13. A catheter as in claim 12, wherein the interface surface has a generally convex shape.

14. A catheter as in claim 1, wherein the catheter body has at least one lumen for delivering a therapeutic agent therethrough.

15. An improved ultrasonic catheter of the type comprising a catheter body having an ultrasonic driver at a distal end thereof, wherein the improvement comprises an ultrasonic driver comprising:

a tail mass secured to the distal end of the catheter body;

an interface member distally spaced-apart from the tail mass;

a spring element connecting the interface member to the tail mass;

an ultrasonic driver disposed between the interface member and the tail mass, wherein said driver oscillates at or near a resonant frequency characteristic of the interface member, the spring element, and the ultrasonic driver.

16. A catheter as in claim 15, wherein the ultrasonic driver comprises a hollow piezoelectric cylinder having an inner cylindrical electrode and an outer cylindrical electrode.

17. A catheter as in claim 16, wherein the piezoelectric cylinder has dimensions and is composed of a material which provide oscillation at a frequency in the range from 10 kHz to 300 kHz.

18. A catheter as in claim 17, wherein the piezoelectric cylinder is composed of a lead zirconate titinate, has a length in the range from 2 mm to 2 cm, an outer diameter in the range from 1 mm to 4 mm, and a wall thickness in the range from 0.1 mm to 0.5 mm.

19. A catheter as in claim 15, wherein the ultrasonic driver comprises a plurality of ceramic disks having electrodes therebetween.

20. A catheter as in claim 15, wherein the tail mass has a mass which is at least four times the mass of the interface member.

21. A catheter as in claim 20, wherein the tail mass has a mass in the range from 0.1 gm to 10 gm and the interface member has a mass in the range from 0.01 gm to 1 gm.

22. A catheter as in claim 15, wherein the spring element comprises at least one rod secured at a proximal end to the tail mass and at a distal end to the interface member.

23. A catheter as in claim 22, wherein the spring element consists of a single rod disposed coaxially within the catheter.

24. A catheter as in claim 22, wherein the spring element comprises at least two parallel rod members disposed symmetrically about the axis of the catheter body.

25. A catheter as in claim 15, wherein the interface member includes a distally disposed interface surface which forwardly transmits longitudinal oscillations into the environment surrounding the distal end of the catheter.

26. A catheter as in claim 25, wherein the interface surface has a generally convex shape.

27. A catheter as in claim 15, wherein the catheter body has at least one lumen for delivering a therapeutic agent therethrough.

28. A method for treating intraluminal lesions, said method comprising:

providing a catheter having an assembly comprising an interface member connected to a tall mass by a spring element disposed at its distal end, wherein the assembly has a resonant frequency;

advancing a forwardly disposed surface of the interface member to a region near the intraluminal lesion;

driving the interface member relative to the tail mass at the resonant frequency, wherein ultrasonic energy is amplified and radiated into the region.

29. A method as in claim 28, wherein the intraluminal lesion contains a vascular stenosis.

30. A method as in claim 29, wherein the interface member surface is engaged against a vascular obstruction.

31. A method as in claim 28, wherein the interface member is driven at a frequency in the range from about 10 kHz to 300 kHz.

32. A method as in claim 31, wherein the interface member is driven with a longitudinal amplitude in the range from 0.05 μ

m to 20 μ

m.

33. A method as in claim 28, wherein the forwardly disposed surface has an area in the range from 0.5 mm² to 20 mm².

34. A method as in claim 28, further comprising delivering a therapeutic agent through the catheter to the intraluminal lesion.

35. A method as in claim 34, wherein the therapeutic agent is delivered while ultrasonic energy is being radiated into the region.

36. A method as in claim 35, wherein the therapeutic agent is a fibrinolytic agent delivered to a vascular stenosis to treat clot.

37. A method as in claim 35, wherein the therapeutic agent is delivered to a previously treated vascular site to inhibit restenosis.